We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
HLK Biotech Holding Group Inc (CE) | USOTC:AMHD | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0002 | 0.00 | 00:00:00 |
This was achieved by purchasing distressed and foreclosed properties at low prices, renovating them, marketing them in house and then selling them at considerably higher prices. Transactions were finalized at Metropolitan Title Company of Ft. Wayne, Indiana.
"I am delighted to report the success of Amelot Properties first full quarter in business. ln spite of the severe winter weather and starting a new business from scratch, we still managed to complete 7 sales and net approximately $21,000 more for those transactions than originally anticipated," stated Fred Guarnieri, President and CEO.
"We are also encouraged by the ongoing talks and numerous inquiries by several real estate investors interested in potential investment in our fast growing niche business," Mr. Guarnieri added.
This week, Mr. Guarnieri will be in Fort Wayne for meetings with Metropolitan Title Company, touring properties as part of a potential bulk purchase and putting a second crew in place.
Amelot Properties plans on announcing April profits in addition to further details regarding its business model early May 2011.
The Company currently has 4,624,573,155 shares outstanding, of which 1,076,275,010 are owned by Mr. Guarnieri.
About Amelot Holdings, Inc. (PINKSHEETS: AMHD):
Amelot Holdings, Inc. (http://www.amelotholdings.com) is a publicly trading company with a diversified portfolio of investments.
Amelot Properties, LLC. (http://www.amelotholdings.com/our-businesses/subsidiaries/amelot-properties-llc) is a wholly owned subsidiary of Amelot Holdings, which acquires, renovates and sells energy efficient properties to prospective home owners at affordable prices. Its success is based on the ability to identify undervalued properties and rehabilitate these properties for future resale or rental investments.
Amelot Oil, Inc. (http://www.amelotholdings.com/our-businesses/subsidiaries/amelot-oil-inc) is a wholly owned subsidiary of Amelot Holdings, focused on alternative energy and bio-fuels. Amelot Oil plans to capture a significant market share by growing low cost feedstocks to supply the growing demand for biodiesel. Biodiesel helps reduce energy dependency of fossil fuels, reduces the U.S. dependency on foreign oil and lowers the negative impact of energy on our environment.
Safe Harbor This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Amelot Holdings, Inc. with members of its management team as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Contact: Amelot Holdings, Inc. 1-(646)-926-3568 support@amelotholdings.com http://www.amelotholdings.com/our-businesses/subsidiaries/amelot-properties-llc
1 Year HLK Biotech (CE) Chart |
1 Month HLK Biotech (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions